BSX Boston Scientific Corporation Common Stock
$49.53
价格 · 八月 24, 2026
截至...的财报数据 八月 3, 2026
52周区间
$42–$110
11% of range
分析师评级
BUY
38 analysts
目标价
$63
+27% upside
P/E (TTM)
49.1
ROE
12.6%
净利润率
14.4%
关于 Boston Scientific Corporation Common Stock 公司概况（来自维基百科）
波士顿科技 是一家美国医疗器械制造商。专注于微创介入医疗器械的研发、生产与销售。
阅读更多
波士顿科技（英語：Boston Scientific）是一家美国医疗器械制造商。专注于微创介入医疗器械的研发、生产与销售。
## 历史
1979年6月成立于美国米德尔塞克斯县马尔伯勒市，1992年5月19日在纽约证券交易所成功上市，1997年进入中国，其大中华区公司总部位于上海。2013年9月在上海成立创新培训学院和创新中心。
2021 年 1 月，波士顿宣布将以高达 12 亿美元的价格收购Preventice Solutions, Inc.及其移动心脏健康解决方案组合。
2021年 3 月，波士顿科技公司宣布将以 10 亿美元收购成立於1966年總部位於以色列耶路撒冷的外科和眼科微创临床设备開發商Lumenis Ltd（科醫人）。
2021年 6 月，波士顿科技公司宣布将以 2.95 亿美元收购 Farapulse, Inc 73% 的股份。该交易补充了现有的电生理学产品组合。
2021年 9 月，波士顿科技公司宣布将收购 Devoro Medical, Inc. 及其血凝块捕获技术。
2021年10月7日，波士顿科技公司 (NYSE:BSX) 已同意以 $1.75B 的预付款收购 Baylis Medical Company。该交易预计将在 2022 年第一季度完成。
== 参考来源 ==
来源：维基百科, CC BY-SA 4.0 · 在维基百科上查看 ↗
BSX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$49.52
市值
—
P/E (TTM)
49.1
每股收益 (TTM)
$1.94
营收 (TTM)
$20.07B
股息收益率
—
ROE
12.6%
负债/权益
—
52周区间
$42 – $110
BSX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$20.07B
2016-12-31
→
2025-12-31
EPS
$1.94
2016-12-31
→
2025-12-31
自由现金流
$3.66B
2017-12-31
→
2025-12-31
利润率
14.4%
2017-12-31
→
2025-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
BSX
同行中位数
P/E (TTM)
49.1
26.3
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
BSX
同行中位数
Gross Margin (毛利率)
69.0%
63.1%
Operating Margin (营业利润率)
18.0%
—
Net Profit Margin (净利润率)
14.4%
15.6%
ROA
7.0%
7.6%
ROE
12.6%
15.0%
ROIC
12.7%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
BSX
同行中位数
Current Ratio (流动比率)
1.6
1.7
Quick Ratio (速动比率)
0.4
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
BSX
同行中位数
Revenue YoY (营收同比增长)
19.9%
—
Revenue CAGR 3Y (营收3年复合年增长率)
16.5%
—
Revenue CAGR 5Y (营收5年复合年增长率)
15.2%
—
EPS YoY
55.2%
—
Net Income YoY (净利润同比增长)
56.7%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
BSX
同行中位数
BSX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
38 位分析师
- 强烈买入 11 28.9%
- 买入 19 50.0%
- 持有 8 21.1%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
29 位分析师 · 2026-08-19
中位数
$60.00
现在
$49.52
最低
$44.00
最高
$94.00
中位数目标
$60.00
+21.2%
平均目标
$62.69
+26.6%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.03%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $0.86 | $0.84 | 0.02% |
| 2026年3月31日 | $0.80 | $0.79 | 0.01% |
| 2025年12月31日 | $0.80 | $0.79 | 0.01% |
| 2025年9月30日 | $0.75 | $0.72 | 0.03% |
| 2025年6月30日 | $0.75 | $0.73 | 0.02% |
| 2025年3月31日 | $0.75 | $0.68 | 0.07% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B | $10.73B | $9.82B | $9.05B | $8.39B | $7.48B | $7.46B | |
| Cost of Revenue | $6.22B | $5.26B | $4.34B | $3.96B | $3.71B | $3.46B | $3.12B | $2.81B | $2.59B | $2.42B | $2.17B | $2.21B | |
| Gross Profit | $13.85B | $11.49B | $9.90B | $8.73B | $8.18B | $6.45B | $7.62B | $7.01B | $6.46B | $5.96B | $5.30B | $5.17B | |
| SG&A Expense | $6.89B | $5.98B | $5.19B | $4.52B | $4.36B | $3.79B | $3.94B | $3.57B | $3.29B | $3.10B | $2.87B | $2.90B | |
| Operating Expenses | $10.24B | $8.89B | $7.55B | $7.08B | $6.98B | $6.53B | $6.10B | $5.50B | $5.17B | $5.51B | $5.59B | $5.47B | |
| Operating Income | $3.61B | $2.60B | $2.34B | $1.65B | $1.20B | $-80M | $1.52B | $1.51B | $1.28B | $447M | $-283M | $-301M | |
| Interest Expense | $349M | $305M | $265M | $470M | $341M | $361M | $473M | $241M | $229M | $233M | $284M | $216M | |
| Other Non-op | $-228M | $-321M | $-358M | $-508M | $218M | $362M | $-358M | $156M | $-124M | $-37M | $-83M | $8M | |
| Pretax Income | $3.38B | $2.28B | $1.99B | $1.14B | $1.08B | $-79M | $687M | $1.42B | $933M | $177M | $-650M | $-509M | |
| Income Tax | $493M | $436M | $393M | $443M | $36M | $2M | $-4.01B | $-249M | $828M | $-170M | $-411M | $-390M | |
| Net Income | $2.89B | $1.85B | $1.59B | $698M | $1.04B | $-82M | $4.70B | $1.67B | $104M | $347M | $-239M | $-119M | |
| EPS (Basic) | $1.96 | $1.26 | $1.08 | $0.45 | $0.69 | $-0.08 | $3.38 | $1.21 | $0.08 | $0.26 | $-0.18 | $-0.09 | |
| EPS (Diluted) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | $-0.08 | $3.33 | $1.19 | $0.08 | $0.25 | $-0.18 | $-0.09 | |
| Shares (Basic) | 1,480,400,000 | 1,471,500,000 | 1,453,000,000 | 1,430,500,000 | 1,422,300,000 | 1,416,700,000 | 1,391,500,000 | 1,381,000,000 | 1,370,100,000 | 1,357,600,000 | 1,341,200,000 | 1,324,300,000 | |
| Shares (Diluted) | 1,494,500,000 | 1,485,900,000 | 1,463,500,000 | 1,439,700,000 | 1,433,800,000 | 1,416,700,000 | 1,410,600,000 | 1,401,400,000 | 1,392,700,000 | 1,377,200,000 | 1,341,200,000 | 1,324,300,000 | |
| EBITDA | $4.98B | $3.87B | · | $2.79B | $2.29B | $1.04B | $2.53B | $2.40B | $2.13B | · | $442M | $424M |
资产负债表 27
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.97B | $414M | $865M | $928M | $1.93B | $1.73B | $217M | $146M | $188M | $196M | $319M | $587M | |
| Inventory | $2.94B | $2.81B | $2.48B | $1.87B | $1.61B | $1.35B | $1.58B | $1.17B | $1.08B | $955M | $1.02B | $946M | |
| Prepaid Expense | $660M | $831M | $621M | $731M | $799M | $751M | $880M | $921M | $942M | $541M | $365M | $443M | |
| Other Current Assets | · | $831M | $621M | $731M | $799M | $751M | $880M | $921M | · | $240M | $254M | · | |
| Current Assets | $8.79B | $6.92B | $6.51B | $5.76B | $6.32B | $6.69B | $4.70B | $4.00B | $3.82B | $3.24B | $3.47B | $3.61B | |
| PP&E (Net) | $4.04B | $3.29B | $2.86B | $2.45B | $2.25B | $2.08B | $2.08B | $1.78B | $1.70B | $1.63B | $1.49B | $1.51B | |
| PP&E (Gross) | $7.64B | $6.83B | $6.34B | $5.73B | $5.53B | $5.31B | $5.17B | $4.74B | $4.62B | $4.37B | $4.06B | $3.85B | |
| Accum. Depreciation | $3.61B | $3.53B | $3.48B | $3.28B | $3.27B | $3.22B | $3.09B | $2.96B | $2.93B | $2.73B | $2.57B | $2.34B | |
| Goodwill | $18.28B | $17.09B | $14.39B | $12.92B | $11.99B | $9.95B | $10.18B | $7.91B | $7.00B | $6.68B | $6.47B | $5.90B | |
| Intangibles | $7.02B | $6.68B | $6.00B | $5.90B | $6.12B | $5.92B | $7.89B | $6.37B | $5.84B | $5.88B | $6.19B | $5.61B | |
| Other Non-current Assets | $1.19B | $1.75B | $1.53B | $1.50B | $1.41B | $1.92B | $1.53B | $845M | $688M | $666M | $505M | $407M | |
| Total Assets | $43.67B | $39.40B | $35.14B | $32.47B | $32.23B | $30.78B | $30.57B | $21.00B | $19.04B | $18.10B | $18.13B | $17.02B | |
| Accounts Payable | $1.14B | $960M | $942M | $862M | $794M | $513M | $542M | $349M | $530M | $447M | $209M | $262M | |
| Accrued Liabilities | $3.20B | $2.77B | $2.65B | $2.16B | $2.44B | $2.20B | $2.11B | $2.25B | $2.46B | $2.31B | $1.97B | $1.95B | |
| Current Liabilities | $5.44B | $6.40B | $4.93B | $3.80B | $4.27B | $3.68B | $4.87B | $5.26B | $5.65B | $3.59B | $2.43B | $2.85B | |
| Capital Leases | $446M | $401M | $390M | $347M | $389M | $401M | $276M | $0 | · | · | · | · | |
| Deferred Tax | $220M | $155M | $134M | $144M | $310M | $330M | $595M | $328M | $191M | $18M | $735M | $1.21B | |
| Other Non-current Liabilities | $2.40B | $1.87B | $1.97B | $2.04B | $2.22B | $2.31B | $2.63B | $1.88B | $2.37B | $2.34B | $2.97B | $2.67B | |
| Long-term Debt | · | · | · | · | · | · | · | · | $3.81B | $5.42B | $5.65B | $4.20B | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | $0 | $400M | |
| Common Stock | $17M | $17M | $17M | $17M | $17M | $17M | $16M | $16M | $16M | $16M | $16M | $16M | |
| Retained Earnings | $5.57B | $2.67B | $819M | $-750M | $-1.39B | $-2.38B | $-2.25B | $-6.95B | $-8.39B | $-8.58B | $-8.93B | $-8.69B | |
| Treasury Stock | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $1.72B | $1.72B | $1.72B | $1.72B | $1.72B | $1.72B | |
| AOCI | $-610M | $275M | $49M | $269M | $263M | $207M | $270M | $33M | $-59M | $1M | $88M | $144M | |
| Stockholders' Equity | $24.23B | $21.77B | $19.28B | $17.57B | $16.62B | $15.33B | $13.88B | $8.73B | $7.01B | $6.73B | $6.32B | $6.46B | |
| Liabilities + Equity | $43.67B | $39.40B | $35.14B | $32.47B | $32.23B | $30.78B | $30.57B | $21.00B | $19.04B | $18.10B | $18.13B | $17.02B | |
| Shares Outstanding | · | · | · | · | · | · | 1,394,922,641 | 1,384,581,760 | 1,373,496,628 | 1,362,104,547 | 1,346,647,516 | 1,327,451,966 |
现金流 19
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.37B | $1.27B | $1.20B | $1.14B | $1.09B | $1.12B | $1.01B | $894M | $844M | $815M | $769M | $725M | |
| Stock-based Comp | $299M | $266M | $233M | $220M | $194M | $170M | $157M | $140M | $127M | $116M | $107M | $103M | |
| Deferred Tax | $-12M | $-90M | $73M | $-7M | $-142M | $-85M | $-4.29B | $-162M | $244M | $-343M | $-605M | $-494M | |
| Amort. of Intangibles | $897M | $856M | $828M | $803M | $741M | $789M | $699M | $599M | $565M | $545M | $495M | $438M | |
| Restructuring | $101M | $16M | $69M | $24M | $40M | $52M | $38M | $36M | $37M | $28M | $26M | $69M | |
| Other Non-cash | $-13M | $144M | · | $-521M | $-316M | $382M | $256M | $-2.23B | $107M | · | $568M | $1.05B | |
| Operating Cash Flow | $4.53B | $3.44B | $2.50B | $1.53B | $1.87B | $1.51B | $1.84B | $310M | $1.43B | $1.18B | $691M | $1.27B | |
| CapEx | $876M | $790M | $711M | $588M | $554M | $376M | $461M | $316M | $319M | $376M | $247M | $259M | |
| Investing Cash Flow | $-2.64B | $-5.69B | $-2.57B | $-2.01B | $-1.60B | $-411M | $-5.04B | $-1.92B | $-1.01B | $-887M | $-2.19B | $-745M | |
| Net Debt Issued | · | · | · | · | · | · | $-3.56B | $-602M | $-1.00B | · | $-1.15B | $0 | |
| Stock Issued | · | · | · | $0 | $0 | $975M | $0 | $0 | $85M | $111M | $114M | $60M | |
| Stock Repurchased | · | · | · | $0 | $0 | $535M | $0 | $0 | · | $0 | $0 | $125M | |
| Net Stock Activity | · | · | · | $0 | $0 | $440M | $123M | $101M | $85M | · | $114M | $-65M | |
| Dividends Paid | · | $0 | $28M | $55M | $55M | $28M | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $-395M | $1.81B | $5M | $-548M | $-95M | $293M | $2.97B | $1.43B | $110M | $-206M | $1.28B | $-150M | |
| Net Change in Cash | $1.54B | $-450M | $-70M | $-1.04B | $173M | $1.39B | $-222M | $-188M | · | $-123M | $-268M | $370M | |
| Taxes Paid | $561M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $3.66B | $2.65B | · | $938M | $1.32B | $1.13B | $1.38B | $-6M | $1.11B | · | $353M | $1.01B | |
| Levered FCF | $3.36B | $2.40B | · | $650M | $986M | $762M | $-1.86B | $-289M | $1.08B | · | $249M | $960M |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.0% | 68.6% | · | 68.8% | 68.8% | 65.0% | 71.0% | 71.4% | 71.3% | · | 65.7% | 69.3% | |
| Operating Margin | 18.0% | 15.5% | · | 13.0% | 10.1% | -0.81% | 14.1% | 15.3% | 14.2% | · | -4.0% | -4.0% | |
| Net Margin | 14.4% | 11.0% | · | 5.5% | 8.8% | -0.83% | 43.8% | 17.0% | 1.1% | · | -3.0% | -1.6% | |
| Pretax Margin | 16.9% | 13.6% | · | 9.0% | 9.0% | -0.80% | 6.4% | 14.5% | 10.3% | · | -8.1% | -6.8% | |
| EBITDA Margin | 24.8% | 23.1% | · | 22.0% | 19.3% | 10.5% | 23.6% | 24.4% | 23.5% | · | 5.5% | 5.7% | |
| ROA | 7.0% | 5.0% | · | 2.2% | 3.3% | -0.27% | 18.2% | 8.3% | 0.56% | · | -1.4% | -0.71% | |
| ROE | 12.6% | 8.7% | · | 4.0% | 6.3% | -0.53% | 41.6% | 21.2% | 1.5% | · | -3.7% | -1.8% | |
| ROIC | 12.7% | 9.7% | · | 5.7% | 7.0% | -0.54% | 74.8% | 20.3% | 2.1% | · | -1.9% | -1.0% |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.1 | · | 1.5 | 1.5 | 1.8 | 1.0 | 0.8 | 0.7 | · | 1.4 | 1.3 | |
| Quick Ratio | 0.4 | 0.1 | · | 0.2 | 0.5 | 0.5 | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.1 | |
| Interest Coverage | 10.4 | 8.5 | · | 3.5 | 3.5 | -0.2 | 3.2 | 6.2 | 5.6 | · | -1.2 | -1.4 |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.4 | |
| Inventory Turnover | 2.2 | 2.0 | · | 2.3 | 2.5 | 2.4 | 2.3 | 2.5 | 2.6 | · | 2.2 | 2.4 |
增长率 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.9% | 17.6% | 12.3% | 6.7% | 19.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 16.5% | 12.1% | 12.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 15.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 55.2% | 16.8% | 137.8% | -34.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 62.7% | 21.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 56.7% | 16.0% | 128.1% | -33.0% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 60.6% | 21.0% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B | $10.73B | $9.82B | $9.05B | $8.39B | $7.48B | $7.46B | |
| Net Income TTM | $2.89B | $1.85B | $1.59B | $698M | $1.04B | $-82M | $4.70B | $1.67B | $104M | $347M | $-239M | $-119M | |
| Market Cap | · | · | · | · | · | · | $63.08B | $48.93B | $34.05B | · | $24.83B | $17.59B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | $24.51B | $17.40B | |
| P/E | 49.1 | 71.5 | 54.0 | 102.8 | 61.6 | -449.4 | 13.6 | 29.7 | 309.9 | 86.5 | -102.4 | -147.2 | |
| P/S | · | · | · | · | · | · | 5.9 | 5.0 | 3.8 | · | 3.3 | 2.4 | |
| P/B | · | · | · | · | · | · | 4.5 | 5.6 | 4.9 | · | 3.9 | 2.7 | |
| P / Cash Flow | · | · | · | · | · | · | 34.4 | 157.8 | 23.9 | · | 41.4 | 13.9 | |
| P / FCF | · | · | · | · | · | · | 45.9 | -8155.2 | 30.8 | · | 70.3 | 17.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | 55.5 | 41.0 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | 69.4 | 17.2 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | 3.3 | 2.3 | |
| Dividend Yield | · | · | · | · | · | · | 0.00% | 0.00% | · | · | · | · | |
| Earnings Yield | 2.0% | 1.4% | 1.8% | 0.97% | 1.6% | -0.22% | 7.4% | 3.4% | 0.32% | 1.2% | -0.98% | -0.68% | |
| Payout Ratio | · | 0.00% | · | 7.9% | 5.3% | -34.2% | · | · | · | · | · | · | |
| Annual Payout | · | $0 | $28M | $55M | $55M | $28M | $0 | $0 | · | · | · | · |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.44B | $5.20B | $5.29B | $5.07B | $5.06B | $4.66B | $4.56B | $4.21B | $4.12B | $3.86B | $3.73B | $3.53B | $3.60B | $3.39B | $3.24B | $3.17B | |
| Cost of Revenue | $1.59B | $1.59B | $1.61B | $1.52B | $1.64B | $1.45B | $1.47B | $1.31B | $1.27B | $1.21B | $1.15B | $1.10B | $1.06B | $1.04B | $1.01B | $979M | |
| Gross Profit | $3.85B | $3.61B | $3.68B | $3.54B | $3.42B | $3.21B | $3.10B | $2.90B | $2.85B | $2.65B | $2.58B | $2.43B | $2.54B | $2.35B | $2.23B | $2.19B | |
| SG&A Expense | $1.80B | $1.78B | $1.83B | $1.74B | $1.72B | $1.60B | $1.61B | $1.56B | $1.45B | $1.36B | $1.38B | $1.24B | $1.35B | $1.22B | $1.16B | $1.13B | |
| Operating Expenses | $2.67B | $2.51B | $2.85B | $2.49B | $2.60B | $2.29B | $2.42B | $2.16B | $2.33B | $1.97B | $2.00B | $1.73B | $2.03B | $1.80B | $1.83B | $1.83B | |
| Operating Income | $1.18B | $1.10B | $825M | $1.05B | $819M | $921M | $675M | $733M | $520M | $675M | $584M | $693M | $514M | $552M | $402M | $358M | |
| Interest Expense | $96M | $90M | $90M | $87M | $90M | $82M | $80M | $79M | $77M | $69M | $64M | $66M | $70M | $65M | $64M | $63M | |
| Other Non-op | $-118M | $61M | $-124M | $-110M | $122M | $-116M | $-89M | $-65M | $-100M | $-67M | $-279M | $-18M | $-18M | $-43M | $-412M | $-51M | |
| Pretax Income | $1.06B | $1.16B | $700M | $939M | $941M | $805M | $585M | $669M | $420M | $608M | $505M | $610M | $426M | $444M | $395M | $245M | |
| Income Tax | $155M | $-176M | $31M | $183M | $146M | $133M | $23M | $200M | $98M | $115M | $1M | $105M | $156M | $131M | $256M | $57M | |
| Net Income | $905M | $1.34B | $670M | $755M | $795M | $672M | $563M | $468M | $322M | $493M | $504M | $504M | $270M | $314M | $140M | $188M | |
| EPS (Basic) | $0.62 | $0.90 | $0.45 | $0.51 | $0.54 | $0.46 | $0.38 | $0.32 | $0.22 | $0.34 | $0.35 | $0.34 | $0.18 | $0.21 | $0.09 | $0.12 | |
| EPS (Diluted) | $0.61 | $0.90 | $0.45 | $0.51 | $0.53 | $0.45 | $0.38 | $0.32 | $0.22 | $0.33 | $0.34 | $0.34 | $0.18 | $0.21 | $0.09 | $0.12 | |
| Shares (Basic) | 1,470,200,000 | 1,484,900,000 | -2,958,400,000 | 1,481,700,000 | 1,479,900,000 | 1,477,200,000 | -2,940,200,000 | 1,472,700,000 | 1,470,600,000 | 1,468,400,000 | -2,893,500,000 | 1,464,500,000 | 1,446,200,000 | 1,435,800,000 | -2,858,600,000 | 1,431,600,000 | |
| Shares (Diluted) | 1,474,800,000 | 1,495,000,000 | -2,987,600,000 | 1,495,500,000 | 1,493,500,000 | 1,493,100,000 | -2,967,400,000 | 1,487,400,000 | 1,484,200,000 | 1,481,700,000 | -2,913,700,000 | 1,475,000,000 | 1,456,200,000 | 1,446,000,000 | -2,876,500,000 | 1,440,000,000 | |
| EBITDA | $1.18B | $1.45B | · | $1.05B | $819M | $1.25B | · | $733M | $520M | $979M | · | $693M | $514M | $837M | · | $358M |
资产负债表 24
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $539M | $1.45B | $1.97B | $1.27B | $534M | $725M | $414M | $2.50B | $2.91B | $2.33B | $865M | $952M | $426M | $570M | $928M | $338M | |
| Inventory | $3.23B | $3.12B | $2.94B | $2.92B | $2.86B | $2.87B | $2.81B | $2.75B | $2.61B | $2.56B | · | $2.40B | $2.25B | $2.05B | · | $1.79B | |
| Prepaid Expense | $760M | $729M | $660M | $701M | $613M | $756M | $831M | $674M | $756M | $671M | · | $741M | $773M | $711M | · | $884M | |
| Other Current Assets | · | · | · | $701M | $613M | $756M | · | $674M | $756M | $671M | · | $741M | $773M | $711M | · | $884M | |
| Current Assets | $7.97B | $8.68B | $8.79B | $8.04B | $7.12B | $7.33B | $6.92B | $8.76B | $8.99B | $8.19B | · | $6.50B | $5.89B | $5.70B | · | $5.14B | |
| PP&E (Net) | $4.13B | $4.06B | $4.04B | $3.79B | $3.46B | $3.39B | $3.29B | $3.07B | $2.95B | $2.90B | · | $2.63B | $2.53B | $2.48B | · | $2.27B | |
| PP&E (Gross) | $7.85B | $7.74B | $7.64B | $7.66B | $7.24B | $7.03B | $6.83B | $6.69B | $6.51B | $6.43B | · | $6.08B | $5.96B | $5.84B | · | $5.46B | |
| Accum. Depreciation | $3.73B | $3.67B | $3.61B | $3.86B | $3.78B | $3.64B | $3.53B | $3.62B | $3.56B | $3.53B | · | $3.45B | $3.43B | $3.36B | · | $3.19B | |
| Goodwill | $18.64B | $18.54B | $18.28B | $18.21B | $18.08B | $17.34B | $17.09B | $15.03B | $14.40B | $14.36B | $14.39B | $13.61B | $13.66B | $13.27B | $12.92B | $12.85B | |
| Intangibles | $6.92B | $7.06B | $7.02B | $7.16B | $7.26B | $6.57B | $6.68B | $5.75B | $5.42B | $5.84B | · | $5.85B | $6.06B | $6.06B | · | $6.06B | |
| Other Non-current Assets | $1.41B | $2.05B | $1.87B | $1.83B | $1.86B | $1.83B | $1.75B | $1.64B | $1.55B | $1.60B | · | $1.60B | $1.59B | $1.48B | · | $1.60B | |
| Total Assets | $45.22B | $44.35B | $43.67B | $42.71B | $41.56B | $40.14B | $39.40B | $38.08B | $37.11B | $36.67B | · | $34.04B | $33.60B | $32.89B | · | $31.95B | |
| Accounts Payable | $1.23B | $1.14B | $1.14B | $1.00B | $962M | $1.00B | $960M | $907M | $906M | $921M | · | $929M | $899M | $868M | · | $803M | |
| Accrued Liabilities | $2.76B | $2.51B | $3.20B | $2.98B | $2.80B | $2.35B | $2.77B | $2.46B | $2.32B | $2.08B | · | $2.25B | $2.16B | $1.92B | · | $1.97B | |
| Current Liabilities | $6.43B | $4.57B | $5.44B | $5.33B | $5.19B | $5.06B | $6.40B | $5.91B | $5.58B | $4.92B | · | $4.58B | $4.56B | $4.08B | · | $3.55B | |
| Capital Leases | · | · | $446M | $445M | $440M | $399M | $401M | $373M | $365M | $382M | · | $400M | $401M | $360M | · | $350M | |
| Deferred Tax | $221M | $219M | $220M | $242M | $226M | $158M | $155M | $138M | $132M | $132M | · | $91M | $135M | $210M | · | $278M | |
| Other Non-current Liabilities | $2.48B | $2.47B | $2.40B | $2.39B | $2.38B | $1.95B | $1.87B | $1.84B | $1.80B | $1.92B | · | $1.86B | $1.93B | $2.00B | · | $1.92B | |
| Common Stock | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | · | $17M | $17M | $17M | · | $17M | |
| Retained Earnings | $7.82B | $6.91B | $5.57B | $4.90B | $4.14B | $3.35B | $2.67B | $2.11B | $1.64B | $1.31B | · | $315M | $-189M | $-450M | · | $-876M | |
| Treasury Stock | $4.32B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | · | $2.25B | $2.25B | $2.25B | · | $2.25B | |
| AOCI | $-304M | $-398M | $-610M | $-689M | $-722M | $-28M | $275M | $-128M | $164M | $132M | · | $231M | $208M | $178M | · | $532M | |
| Stockholders' Equity | $24.93B | $25.86B | $24.23B | $23.39B | $22.42B | $22.21B | $21.77B | $20.71B | $20.37B | $19.93B | · | $18.89B | $18.23B | $17.85B | $17.57B | $17.64B | |
| Liabilities + Equity | $45.22B | $44.35B | $43.67B | $42.71B | $41.56B | $40.14B | $39.40B | $38.08B | $37.11B | $36.67B | · | $34.04B | $33.60B | $32.89B | · | $31.95B |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $355M | $351M | $365M | $342M | $336M | $325M | $348M | $306M | $311M | $304M | $313M | $300M | $298M | $285M | $294M | $284M | |
| Stock-based Comp | $87M | $83M | $71M | $79M | $75M | $74M | $69M | $68M | $66M | $63M | $59M | $59M | $60M | $55M | $55M | $58M | |
| Amort. of Intangibles | $233M | $232M | $228M | $225M | $225M | $219M | $224M | $205M | $213M | $214M | $207M | $208M | $210M | $203M | $199M | $202M | |
| Restructuring | $8M | $3M | $16M | $-8M | $83M | $10M | $4M | $8M | $1M | $3M | $18M | $15M | $16M | $20M | $5M | $4M | |
| Other Non-cash | · | $-1.43B | · | · | · | $-530M | · | · | · | $-696M | · | · | · | $-464M | · | · | |
| Operating Cash Flow | $1.47B | $348M | $1.36B | $1.34B | $1.29B | $541M | $1.46B | $1.00B | $813M | $164M | $957M | $698M | $658M | $190M | $807M | $470M | |
| CapEx | $195M | $177M | $351M | $181M | $157M | $187M | $277M | $179M | $155M | $179M | $267M | $190M | $143M | $111M | $212M | $150M | |
| Investing Cash Flow | $-1.96B | $-591M | $-512M | $-502M | $-1.13B | $-500M | $-3.70B | $-1.43B | $-271M | $-285M | $-1.05B | $-197M | $-840M | $-484M | $-183M | $-225M | |
| Dividends Paid | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $14M | $14M | $13M | $14M | |
| Financing Cash Flow | $-410M | $-260M | $-184M | $-104M | $-340M | $233M | $214M | $7M | $24M | $1.57B | $15M | $16M | $43M | $-69M | $1M | $-199M | |
| Net Change in Cash | $-890M | $-504M | $671M | $735M | $-179M | $314M | $-2.04B | $-412M | $565M | $1.44B | $-77M | $513M | $-143M | $-363M | $629M | $39M | |
| Free Cash Flow | · | $171M | · | · | · | $354M | · | · | · | $-15M | · | · | · | $79M | · | · | |
| Levered FCF | · | $67M | · | · | · | $286M | · | · | · | $-71M | · | · | · | $33M | · | · |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.7% | 69.5% | · | 69.9% | 67.7% | 68.8% | · | 68.8% | 69.2% | 68.7% | · | 68.8% | 70.6% | 69.3% | · | 69.1% | |
| Operating Margin | 21.6% | 21.2% | · | 20.7% | 16.2% | 19.8% | · | 17.4% | 12.6% | 17.5% | · | 19.7% | 14.3% | 16.3% | · | 11.3% | |
| Net Margin | 16.6% | 25.7% | · | 14.9% | 15.7% | 14.4% | · | 11.1% | 7.8% | 12.8% | · | 14.3% | 7.5% | 9.3% | · | 5.9% | |
| Pretax Margin | 19.5% | 22.3% | · | 18.5% | 18.6% | 17.3% | · | 15.9% | 10.2% | 15.8% | · | 17.3% | 11.8% | 13.1% | · | 7.7% | |
| EBITDA Margin | 21.6% | 27.9% | · | 20.7% | 16.2% | 26.7% | · | 17.4% | 12.6% | 25.4% | · | 19.7% | 14.3% | 24.7% | · | 11.3% | |
| ROA | 2.1% | 3.2% | · | 1.9% | 2.0% | 1.8% | · | 1.3% | 0.91% | 1.4% | · | 1.5% | 0.82% | 0.96% | · | 0.59% | |
| ROE | 3.8% | 5.6% | · | 3.4% | 3.7% | 3.2% | · | 2.4% | 1.7% | 2.6% | · | 2.8% | 1.5% | 1.8% | · | 1.1% | |
| ROIC | 4.0% | 4.9% | · | 3.6% | 3.1% | 3.5% | · | 2.5% | 2.0% | 2.8% | · | 3.0% | 1.8% | 2.2% | · | 1.6% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.9 | · | 1.5 | 1.4 | 1.5 | · | 1.5 | 1.6 | 1.7 | · | 1.4 | 1.3 | 1.4 | · | 1.4 | |
| Quick Ratio | 0.1 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.4 | 0.5 | 0.5 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | 12.3 | 12.2 | · | 12.0 | 9.1 | 11.2 | · | 9.3 | 6.8 | 9.8 | · | 10.5 | 7.3 | 8.5 | · | 5.7 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 |
估值 (TTM) 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.77B | $19.99B | · | $19.00B | $18.05B | $16.85B | · | $15.71B | $15.10B | $14.37B | · | $13.69B | $13.40B | $12.83B | · | $12.37B | |
| Net Income TTM | $3.79B | $3.56B | · | $2.69B | $2.26B | $1.96B | · | $1.79B | $1.59B | $1.58B | · | $1.28B | $1.03B | $872M | · | $977M | |
| P/E | 16.7 | 26.3 | · | 53.9 | 70.7 | 76.4 | · | 69.3 | 72.0 | 64.6 | · | 62.1 | 79.5 | 87.8 | · | 60.5 | |
| Earnings Yield | 6.0% | 3.8% | · | 1.8% | 1.4% | 1.3% | · | 1.4% | 1.4% | 1.6% | · | 1.6% | 1.3% | 1.1% | · | 1.7% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | 0.00% | · | · | · | 4.5% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B |
| 毛利率 % | 69.0% | 68.6% | — | 68.8% | 68.8% |
| 营业利润率 % | 18.0% | 15.5% | — | 13.0% | 10.1% |
| 净收入 | $2.89B | $1.85B | $1.59B | $698M | $1.04B |
| 稀释后每股收益 (EPS) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 1.6 | 1.1 | — | 1.5 | 1.5 |
| 速动比率 | 0.4 | 0.1 | — | 0.2 | 0.5 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $3.66B | $2.65B | — | $938M | $1.32B |
最新新闻 提及该公司的近期头条新闻
- Boston Scientific’s Quarterly Earnings Preview: What You Need to Know
- BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock
- Boston Scientific Becomes Oversold (BSX)
- Why Boston Scientific Stock Was Sliding This Week
- 波士顿科学股价因20亿美元回购和米鲁投资上涨 (BSX)
- Piper Sandler 维持对 Boston Scientific Corp (BSX) 的超配评级
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 1691 家申报者 · $37.7B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 161 (-79 与上一季度对比) | 315 (+42 与上一季度对比) | 606 (-84 与上一季度对比) | 607 (-23 与上一季度对比) | +23.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $4143696762 | 97087553 | 10.98% | 股份 |
| STATE STREET CORP | $2992345845 | 70111196 | 7.93% | 股份 |
| PRIMECAP MANAGEMENT CO/CA/ | $2156232608 | 50520914 | 5.72% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1271556448 | 29792794 | 3.37% | 股份 |
| FMR LLC | $1239549312 | 29042861 | 3.29% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $1212072881 | 28557132 | 3.21% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $994184207 | 23293913 | 2.64% | 股份 |
| NORGES BANK | $903536838 | 21170029 | 2.40% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $826243102 | 19359023 | 2.19% | 股份 |
| Capital World Investors | $717600310 | 16812257 | 1.90% | 股份 |
| JANE STREET GROUP, LLC | $686580356 | 16086700 | 1.82% | 买入期权 |
| WELLINGTON MANAGEMENT GROUP LLP | $633296809 | 14838257 | 1.68% | 股份 |
| Capital Research Global Investors | $605255716 | 14180571 | 1.60% | 股份 |
| TWO SIGMA ADVISERS, LP | $600558161 | 6298460 | 1.59% | 股份 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $449044133 | 10521184 | 1.19% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $395319403 | 9262404 | 1.05% | 股份 |
| Qube Research & Technologies Ltd | $381720146 | 8943771 | 1.01% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $356182867 | 8345428 | 0.94% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $325241617 | 7620469 | 0.86% | 股份 |
| MORGAN STANLEY | $278890927 | 6534464 | 0.74% | 股份 |
| D. E. Shaw & Co., Inc. | $254250351 | 5957131 | 0.67% | 股份 |
| MAVERICK CAPITAL LTD | $253414762 | 5937553 | 0.67% | 股份 |
| Ensign Peak Advisors, Inc | $251016744 | 5881367 | 0.67% | 股份 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $243577742 | 3881717 | 0.65% | 股份 |
| UBS Group AG | $240594117 | 5637163 | 0.64% | 股份 |
| JANE STREET GROUP, LLC | $238521448 | 5588600 | 0.63% | 卖出期权 |
| BlackRock, Inc. | $234043121 | 5483672 | 0.62% | 股份 |
| LAZARD ASSET MANAGEMENT LLC | $227443076 | 5329032 | 0.60% | 股份 |
| Clearbridge Investments, LLC | $218981454 | 5130774 | 0.58% | 股份 |
| JARISLOWSKY, FRASER Ltd | $214082478 | 2192794 | 0.57% | 股份 |
| BANK OF AMERICA CORP /DE/ | $211692928 | 4960003 | 0.56% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $210735360 | 5437567 | 0.56% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $208893933 | 4894422 | 0.55% | 股份 |
| 1832 Asset Management L.P. | $194487468 | 4556876 | 0.52% | 股份 |
| Holocene Advisors, LP | $180429700 | 4227500 | 0.48% | 买入期权 |
| Swiss National Bank | $178906024 | 4191800 | 0.47% | 股份 |
| JANE STREET GROUP, LLC | $178652846 | 4185868 | 0.47% | 股份 |
| Assenagon Asset Management S.A. | $178127498 | 4173559 | 0.47% | 股份 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $170906014 | 4042830 | 0.45% | 股份 |
| National Pension Service | $168995643 | 3959598 | 0.45% | 股份 |
| Legal & General Group Plc | $160927972 | 3770571 | 0.43% | 股份 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $154393705 | 3617472 | 0.41% | 股份 |
| Ninety One UK Ltd | $149464716 | 3501985 | 0.40% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $146301705 | 3427875 | 0.39% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $144322114 | 2299954 | 0.38% | 股份 |
| Employees Provident Fund Board | $143349316 | 3358700 | 0.38% | 股份 |
| Vanguard Global Advisers, LLC | $142456877 | 3337790 | 0.38% | 股份 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $139790914 | 3275326 | 0.37% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $135035252 | 3163900 | 0.36% | 买入期权 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $134976349 | 3162285 | 0.36% | 股份 |
| Caisse de depot et placement du Quebec | $133178416 | 3120394 | 0.35% | 股份 |
| Alecta Tjanstepension Omsesidigt | $133002390 | 3117000 | 0.35% | 股份 |
| Mirova US LLC | $132371081 | 3101478 | 0.35% | 股份 |
| BARCLAYS PLC | $131524822 | 3081650 | 0.35% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $122627792 | 2873191 | 0.33% | 股份 |
| Public Sector Pension Investment Board | $119712961 | 2804896 | 0.32% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $115346242 | 2702583 | 0.31% | 股份 |
| RHUMBLINE ADVISERS | $112753784 | 2641843 | 0.30% | 股份 |
| Rathbones Group PLC | $108402974 | 2539901 | 0.29% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $102944373 | 2412005 | 0.27% | 股份 |
| Temasek Holdings (Private) Ltd | $102407502 | 2399426 | 0.27% | 股份 |
| Pictet Asset Management Holding SA | $102158094 | 2393080 | 0.27% | 股份 |
| Unisphere Establishment | $101911304 | 2387800 | 0.27% | 股份 |
| MILFORD FUNDS LTD | $92593577 | 2169484 | 0.25% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $91340092 | 1455619 | 0.24% | 股份 |
| HSBC HOLDINGS PLC | $90846130 | 2128541 | 0.24% | 股份 |
| GOLDMAN SACHS GROUP INC | $89773112 | 2103400 | 0.24% | 买入期权 |
| NOMURA HOLDINGS INC | $88556732 | 2074900 | 0.23% | 买入期权 |
| Cubist Systematic Strategies, LLC | $88171996 | 903124 | 0.23% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $87691368 | 2054624 | 0.23% | 股份 |
| California Public Employees Retirement System | $87402153 | 2047848 | 0.23% | 股份 |
| Phoenix Financial Ltd. | $82560747 | 1934413 | 0.22% | 股份 |
| Nuveen Asset Management, LLC | $76820023 | 860054 | 0.20% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $73919754 | 1731953 | 0.20% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $73776648 | 1728600 | 0.20% | 卖出期权 |
| FIRST MANHATTAN CO. LLC. | $72442215 | 1697334 | 0.19% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $71276539 | 1670022 | 0.19% | 股份 |
| Banque Transatlantique SA | $71260298 | 914874 | 0.19% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $70441674 | 1650461 | 0.19% | 股份 |
| ROYAL BANK OF CANADA | $70272000 | 1646479 | 0.19% | 股份 |
| Squarepoint Ops LLC | $69351970 | 1624929 | 0.18% | 股份 |
| D. E. Shaw & Co., Inc. | $68616636 | 1607700 | 0.18% | 卖出期权 |
| GROUPAMA ASSET MANAGMENT | $68098768 | 1571750 | 0.18% | 股份 |
| Lansforsakringar Fondforvaltning AB (publ) | $67481689 | 1581108 | 0.18% | 股份 |
| Walleye Capital LLC | $67356381 | 1578172 | 0.18% | 股份 |
| Squarepoint Ops LLC | $66922240 | 1568000 | 0.18% | 买入期权 |
| VANGUARD GROUP INC | $66616468 | 698652 | 0.18% | 股份 |
| GOLDMAN SACHS GROUP INC | $65853458 | 1542958 | 0.17% | 股份 |
| CAPITAL FUND MANAGEMENT S.A. | $63426577 | 1486096 | 0.17% | 股份 |
| ORBIMED ADVISORS LLC | $63302976 | 1483200 | 0.17% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $63065547 | 1477637 | 0.17% | 股份 |
| CAXTON ASSOCIATES LP | $62622699 | 701105 | 0.17% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $62259456 | 1458786 | 0.17% | 股份 |
| AVIVA PLC | $61094158 | 1431447 | 0.16% | 股份 |
| Navera Investment Management Ltd. | $60925063 | 1427592 | 0.16% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $60808373 | 1424751 | 0.16% | 股份 |
| JONES FINANCIAL COMPANIES LLLP | $56948391 | 1287551 | 0.15% | 股份 |
| MENORA MIVTACHIM HOLDINGS LTD. | $56913780 | 1333500 | 0.15% | 股份 |
| Schonfeld Strategic Advisors LLC | $56634266 | 1326951 | 0.15% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $56124200 | 1315000 | 0.15% | 股份 |
公司内部人士 90 位内幕人士 · 30 位高管 · 18 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| William Kucheman | Chief Executive Officer | 2012年7月31日 P | 112525 | 0 | 0 | $0 |
| James R Tobin | President & CEO | 2009年2月24日 A | 550000 | 0 | 0 | $0 |
| Jeffrey D Capello | EVP & Chief Financial Officer | 2013年11月27日 S | 447 | 0 | 0 | $0 |
| Paul A Laviolette | COO | 2008年7月1日 M | 63072 | 0 | 0 | $0 |
| Joseph Michael Fitzgerald | EVP & Group Pres, Cardiology | 2026年7月31日 I | 64198 | 0 | 7 | $-15168204 |
| Karen Prange | SVP&Pres, Uro & Pelvic Health | 2016年3月8日 S | 38395 | 0 | 0 | $0 |
| Jean Fitterer Lance | SVP, Asst GC, Bus & Regions | 2015年2月16日 M | 117174 | 0 | 0 | $0 |
| John Michael Onuscheck | SVP & President, Europe | 2015年1月1日 M | 116025 | 0 | 0 | $0 |
| Kenneth Pucel | EVP, Glob Ops, Qual & Tech | 2014年2月28日 M | 128517 | 0 | 0 | $0 |
| Otha T. Spriggs III | SVP, Human Resources | 2012年9月7日 M | 12738 | 0 | 0 | $0 |
| Lawrence R Neumann | SVP, Special Projects | 2012年5月10日 M | 77879 | 0 | 0 | $0 |
| Brian R Burns | EVP - Global Quality & Reg Aff | 2012年2月28日 M | 79418 | 0 | 0 | $0 |
| John B. Pedersen | Pres, Uro & Women's Health | 2012年2月16日 M | 3233 | 0 | 0 | $0 |
| Stephen F Moreci | SVP, Global Sales Operations | 2011年7月1日 M | 37362 | 0 | 0 | $0 |
| Sam R Leno | EVP & Chief Operations Officer | 2011年6月6日 M | 432240 | 0 | 0 | $0 |
| Fred Colen | EVP & Chief Technology Officer | 2010年5月10日 M | 72497 | 0 | 0 | $0 |
| James Gilbert | EVP, Strategy & Business Dev | 2010年2月26日 A | 67613 | 0 | 0 | $0 |
| David W Mcfaul | SVP, International | 2010年2月12日 M | 41426 | 0 | 0 | $0 |
| Donovan Paul | SVP, Corporate Communications | 2010年2月12日 M | 33103 | 0 | 0 | $0 |
| William F Mcconnell JR | SVP, Administration CRM | 2009年7月24日 M | 55204 | 0 | 0 | $0 |
| Donald S Baim | EVP, Chief Med. & Sci. Officer | 2009年7月10日 M | 51756 | 0 | 0 | $0 |
| Lucia Luce Quinn | Exec. Vice President-HR | 2009年7月1日 M | 49809 | 0 | 0 | $0 |
| Paul W Sandman | EVP and General Counsel | 2008年2月29日 M | 66846 | 0 | 0 | $0 |
| Jeffrey H Goodman | SVP, International | 2007年7月1日 M | 10460 | 0 | 0 | $0 |
| Lawrence C Best | EVP | 2007年7月1日 F | 242189 | 0 | 0 | $0 |
| Mark C Bartell | SVP Global Sales/Mkt CRM | 2007年5月25日 M | 1812 | 0 | 0 | $0 |
| Mary E Russell | SVP and CMO | 2006年1月3日 D | 4706 | 0 | 0 | $0 |
| James H Taylor JR | Sr. VP, Operations | 2005年2月9日 M | 9360 | 0 | 0 | $0 |
| Dennis A Ocwieja | SVP, Regulatory | 2005年1月3日 A | — | 0 | 0 | $0 |
| Robert G Maclean | SVP, HR | 2005年1月3日 A | 36502 | 0 | 0 | $0 |
| Edward J Ludwig | 董事 | 2026年7月31日 P | 30359 | 2 | 0 | $430314 |
| JOHNSON KRISTINA M | 董事 | 2016年5月3日 A | 8494 | 0 | 0 | $0 |
| Nicholas J Nicholas JR | 董事 | 2016年4月1日 A | 0 | 0 | 0 | $0 |
| NICHOLAS PETER M | 董事 | 2016年4月1日 A | 3486965 | 0 | 0 | $0 |
| Ernest Mario | 董事 | 2015年11月16日 S | 86032 | 0 | 0 | $0 |
| Uwe E Reinhardt | 董事 | 2014年10月31日 A | 159379 | 0 | 0 | $0 |
| Bruce L Byrnes | 董事 | 2014年10月31日 A | 112097 | 0 | 0 | $0 |
| Katharine T Bartlett | 董事 | 2013年5月7日 A | 52464 | 0 | 0 | $0 |
| John Raymond Elliott | 董事 | 2012年2月27日 A | 603676 | 0 | 0 | $0 |
| Ray J Groves | 董事 | 2011年3月31日 A | 1000 | 0 | 0 | $0 |
| Marye Anne Fox | 董事 | 2010年5月11日 A | 21111 | 0 | 0 | $0 |
| John E Pepper | 董事 | 2010年3月31日 A | 58807 | 0 | 0 | $0 |
| Ursula M Burns | 董事 | 2009年5月5日 A | 32001 | 0 | 0 | $0 |
| Warren B Rudman | 董事 | 2009年5月5日 A | — | 0 | 0 | $0 |
| Nancy Ann Deparle | 董事 | 2008年5月6日 A | 13886 | 0 | 0 | $0 |
| Joel Lawrence Fleishman | 董事 | 2008年5月6日 A | 125691 | 0 | 0 | $0 |
| PROMERICA LP | 10% 所有者 | 2007年8月7日 J | 54635185 | 0 | 0 | $0 |
| Emily Woodworth | — | 2026年8月11日 I | 2930 | 0 | 0 | $0 |
| Jonathan Monson | — | 2026年8月10日 I | 9908 | 0 | 0 | $0 |
| David C Habiger | — | 2026年8月5日 P | 17160 | 5 | 0 | $407941 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 7 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Boston Scientific Corporation, Boston Scientific Scimed, Inc. | 2008年4月25日 | — | 初始申报 | 并购/出售 | SEC |
| GUIDANT CORPORATION ( | 2006年2月3日 | — | 初始申报 | 并购/出售 | SEC |
| 未披露的报告人 | 2003年2月14日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2003年2月14日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2002年6月27日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2002年5月23日 | — | 初始申报 | 并购/出售 | SEC |
| 未披露的报告人 | 2001年7月9日 | — | 初始申报 | 并购/出售 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 214 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IHI · iShares Trust | 4.12% | 2873679 SH | 2026年8月21日 | 每日 |
| GDOC · Goldman Sachs ETF Trust | 3.78% | 15740 NS | 2026年5月31日 | N-PORT |
| AGNG · Global X Funds | 2.44% | 41335 NS | 2026年5月31日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 2.04% | 3946 NS | 2026年4月30日 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.68% | 15586 NS | 2026年4月30日 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Inde... | 1.66% | 59686 SH | 2026年8月21日 | 每日 |
| RUNN · Strategic Trust | 1.54% | 109930 NS | 2026年5月31日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.48% | 245399 SH | 2026年8月21日 | 每日 |
| FMED · Fidelity Covington Trust | 1.44% | 12185 NS | 2026年5月31日 | N-PORT |
| HRTS · Tema ETF Trust | 1.42% | 15285 NS | 2026年5月31日 | N-PORT |
| MDEV · First Trust Exchange-Traded Fund VI | 1.42% | 637 NS | 2026年6月30日 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.40% | 648801 SH | 2026年8月21日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 1.38% | 683394 NS | 2026年4月30日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1.23% | 29571 NS | 2026年4月30日 | N-PORT |
| IYH · iShares Trust | 1.13% | 884504 SH | 2026年8月21日 | 每日 |
| MEDI · Harbor ETF Trust | 1.10% | 5252 NS | 2026年4月30日 | N-PORT |
| RXL · ProShares Trust | 1.04% | 15464 NS | 2026年5月31日 | N-PORT |
| RND · First Trust Exchange-Traded Fund VI | 1.03% | 1162 NS | 2026年6月30日 | N-PORT |
| ESLG · Strategy Shares | 0.97% | 3256 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.93% | 4467628 SH | 2026年8月19日 | 每日 |
| ANEW · ProShares Trust | 0.92% | 1476 NS | 2026年5月31日 | N-PORT |
| IXJ · iShares Trust | 0.89% | 781782 SH | 2026年8月21日 | 每日 |
| KNO · INVESTMENT MANAGERS SERIES TRUST II | 0.88% | 9340 NS | 2026年6月30日 | N-PORT |
| GURU · Global X Funds | 0.83% | 8375 NS | 2026年4月30日 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS T... | 0.79% | 14552 NS | 2026年4月30日 | N-PORT |
| PSET · Principal Exchange-Traded Funds | 0.74% | 5002 NS | 2026年6月30日 | N-PORT |
| ESLV · Strategy Shares | 0.66% | 1338 NS | 2026年4月30日 | N-PORT |
| DTEC · ALPS ETF Trust | 0.63% | 9723 NS | 2026年5月31日 | N-PORT |
| ESUM · Strategy Shares | 0.62% | 16531 NS | 2026年4月30日 | N-PORT |
| NBGX · Neuberger Berman ETF Trust | 0.60% | 1844 NS | 2026年5月31日 | N-PORT |
| DAK · EA Series Trust | 0.58% | 5206 NS | 2026年5月29日 | N-PORT |
| IIGD · Invesco Exchange-Traded Self-Inde... | 0.56% | 160000 | 2026年8月21日 | 每日 |
| FFLC · FIDELITY COVINGTON TRUST | 0.54% | 105660 NS | 2026年4月30日 | N-PORT |
| ZECP · Zacks Trust | 0.52% | 36519 NS | 2026年5月31日 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.46% | 91846 SH | 2026年8月19日 | 每日 |
| FFLG · FIDELITY COVINGTON TRUST | 0.46% | 46964 NS | 2026年4月30日 | N-PORT |
| THMZ · Lazard Active ETF Trust | 0.45% | 5654 NS | 2026年6月30日 | N-PORT |
| INFO · Harbor ETF Trust | 0.43% | 57055 NS | 2026年4月30日 | N-PORT |
| XOEF · iShares Trust | 0.40% | 1861 SH | 2026年8月21日 | 每日 |
| CATH · Global X Funds | 0.40% | 83468 NS | 2026年4月30日 | N-PORT |
| RCGE · EA Series Trust | 0.39% | 6410 NS | 2026年4月30日 | N-PORT |
| JGLO · J.P. Morgan Exchange-Traded Fund ... | 0.39% | 477916 NS | 2026年4月30日 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0.39% | 230737 NS | 2026年5月31日 | N-PORT |
| SNPG · DBX ETF Trust | 0.38% | 1068 NS | 2026年5月29日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 0.37% | 56542 NS | 2026年4月30日 | N-PORT |
| KRMA · Global X Funds | 0.36% | 8982 NS | 2026年5月31日 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund ... | 0.36% | 250378 NS | 2026年4月30日 | N-PORT |
| CRTC · DBX ETF Trust | 0.33% | 8980 NS | 2026年5月31日 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Inde... | 0.30% | 8685000 | 2026年8月21日 | 每日 |
| OEI · Listed Funds Trust | 0.29% | 2132 NS | 2026年4月30日 | N-PORT |